Tony L Kille, MD | |
600 Highland Ave, Madison, WI 53792-0001 | |
(608) 263-6190 | |
(608) 263-6199 |
Full Name | Tony L Kille |
---|---|
Gender | Male |
Speciality | Otolaryngology - Pediatric Otolaryngology |
Location | 600 Highland Ave, Madison, Wisconsin |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518918952 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207YP0228X | Otolaryngology - Pediatric Otolaryngology | 44804-20 (Wisconsin) | Primary |
Entity Name | University Of Wisconsin Medical Foundation Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598784555 PECOS PAC ID: 6608785464 Enrollment ID: O20031111000435 |
News Archive
Officials announced today that Baylor Research Institute (BRI), part of the Baylor Health Care System, was recently re-accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). The re-accreditation certifies that BRI maintains efficient systems for monitoring research participant safety and embraces ethical standards higher than required by law in order to protect human participants participating in BRI research programs. Only 200 out of the thousands of human research protection programs in the U.S., Canada and abroad have earned this prestigious distinction.
Hematology researchers have used a single injection of gene therapy to correct a rare bleeding disorder, factor VII deficiency, in dogs. This success in large animals holds considerable potential for a safe, effective and long-lasting new treatment in humans with the same bleeding disorder.
ILiAD Biotechnologies, LLC, the French National Institute of Health and Medical Research subsidiary, Inserm Transfert SA, and Institut Pasteur de Lille today announced the signing of scientific collaboration and worldwide license agreements for live attenuated Bordetella pertussis vaccine technology, including BPZE1, developed by the laboratory of Professor Camille Locht. This license agreement covers patent rights from Institut Pasteur de Lille, Inserm, National University of Singapore and National University of Ireland Maynooth.
Politico: States with "the most progressive health policies" are having a hard time implementing their part of a $5 billion series of high-risk insurance pools because their states offer a more generous guarantee of coverage. "Five states — Vermont, Maine, New York, New Jersey and Massachusetts — have 'guaranteed issue' of insurance: individual subscribers cannot be turned away because of a health condition.
› Verified 2 days ago
Entity Name | University Of Wisconsin System Non Payroll |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346266319 PECOS PAC ID: 9133024888 Enrollment ID: O20031204001102 |
News Archive
Officials announced today that Baylor Research Institute (BRI), part of the Baylor Health Care System, was recently re-accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). The re-accreditation certifies that BRI maintains efficient systems for monitoring research participant safety and embraces ethical standards higher than required by law in order to protect human participants participating in BRI research programs. Only 200 out of the thousands of human research protection programs in the U.S., Canada and abroad have earned this prestigious distinction.
Hematology researchers have used a single injection of gene therapy to correct a rare bleeding disorder, factor VII deficiency, in dogs. This success in large animals holds considerable potential for a safe, effective and long-lasting new treatment in humans with the same bleeding disorder.
ILiAD Biotechnologies, LLC, the French National Institute of Health and Medical Research subsidiary, Inserm Transfert SA, and Institut Pasteur de Lille today announced the signing of scientific collaboration and worldwide license agreements for live attenuated Bordetella pertussis vaccine technology, including BPZE1, developed by the laboratory of Professor Camille Locht. This license agreement covers patent rights from Institut Pasteur de Lille, Inserm, National University of Singapore and National University of Ireland Maynooth.
Politico: States with "the most progressive health policies" are having a hard time implementing their part of a $5 billion series of high-risk insurance pools because their states offer a more generous guarantee of coverage. "Five states — Vermont, Maine, New York, New Jersey and Massachusetts — have 'guaranteed issue' of insurance: individual subscribers cannot be turned away because of a health condition.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Tony L Kille, MD 7974 Uw Health Ct, Middleton, WI 53562-5531 Ph: () - | Tony L Kille, MD 600 Highland Ave, Madison, WI 53792-0001 Ph: (608) 263-6190 |
News Archive
Officials announced today that Baylor Research Institute (BRI), part of the Baylor Health Care System, was recently re-accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). The re-accreditation certifies that BRI maintains efficient systems for monitoring research participant safety and embraces ethical standards higher than required by law in order to protect human participants participating in BRI research programs. Only 200 out of the thousands of human research protection programs in the U.S., Canada and abroad have earned this prestigious distinction.
Hematology researchers have used a single injection of gene therapy to correct a rare bleeding disorder, factor VII deficiency, in dogs. This success in large animals holds considerable potential for a safe, effective and long-lasting new treatment in humans with the same bleeding disorder.
ILiAD Biotechnologies, LLC, the French National Institute of Health and Medical Research subsidiary, Inserm Transfert SA, and Institut Pasteur de Lille today announced the signing of scientific collaboration and worldwide license agreements for live attenuated Bordetella pertussis vaccine technology, including BPZE1, developed by the laboratory of Professor Camille Locht. This license agreement covers patent rights from Institut Pasteur de Lille, Inserm, National University of Singapore and National University of Ireland Maynooth.
Politico: States with "the most progressive health policies" are having a hard time implementing their part of a $5 billion series of high-risk insurance pools because their states offer a more generous guarantee of coverage. "Five states — Vermont, Maine, New York, New Jersey and Massachusetts — have 'guaranteed issue' of insurance: individual subscribers cannot be turned away because of a health condition.
› Verified 2 days ago
Charles N Ford, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6190 Fax: 608-263-6199 | |
Ruth Jennifer Davis, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6190 Fax: 608-263-6199 | |
Chelsea M Kruse, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: Uw Hospitals & Clinics 600 Highland Ave, Madison, WI 53792 Phone: 563-880-4962 | |
Jason S Isenberg, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1211 Fish Hatchery Rd, Madison, WI 53715 Phone: 608-252-8000 Fax: 608-283-7381 | |
Dr. Ian Joseph Koszewski, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: Uw Hospital And Clinics, 600 Highland Ave, H4/831, Madison, WI 53792 Phone: 608-263-0192 | |
Dr. Joseph Paul Roche, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6190 Fax: 608-263-6199 | |
Dr. Paula Demetrio De Souza Franca, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6400 |